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Abstract
The lethality of pancreatic adenocarcinoma stems from an elevated incidence of tumor cell invasion and metas-
tasis that are mediated by mechanisms not yet understood. Recent studies indicate that the proinvasive integrin
α6β4 is highly upregulated in pancreatic adenocarcinomas. To assess the importance of this integrin in pancreatic
cancer cell migration and invasion, cell lines were screened for integrin α6β4 expression by immunoblotting and
fluorescence-activated cell sorting and their ability to migrate and invade toward hepatocyte growth factor (HGF).
We found that cell surface expression of the α6β4 integrin correlated with the cells’ ability to migrate and invade
toward HGF. When cells expressing high levels of integrin α6β4 were treated with small interfering RNA targeting
α6 or β4 integrin subunits, we observed a reduction in cell migration and invasion. Furthermore, the activity of the
small GTPase Rac1 was stimulated by α6β4 integrin expression and was necessary for HGF-stimulated chemotaxis.
We discovered that expression of the Rac-specific nucleotide exchange factor, Tiam1 (T-lymphoma invasion and
metastasis), was upregulated in cells overexpressing the integrin α6β4 and required for the elevated Rac1 activity
in these cells. We conclude that the integrin α6β4 promotes the migratory and invasive phenotype of pancreatic
carcinoma cells through the Tiam1-Rac1 pathway in part through the upregulation of Tiam1.
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Introduction
Pancreatic adenocarcinoma is a highly invasive and metastatic cancer
that has the highest mortality rate of all cancers for reasons that are
not yet understood [1]. Integrins are involved in multiple aspects of
tumor invasion and metastasis, making them good candidates to elu-
cidate the basic mechanisms involved in the metastatic process [2,3].
Our group as well as others has shown that the proinvasive and pro-
metastatic integrin α6β4 is overexpressed in pancreatic adenocar-
cinomas [4–8] when compared to normal pancreas and chronic
pancreatitis. Furthermore, this overexpression occurs at an early stage
in pancreatic cancer progression [8]. The early and persistent upre-
gulation of integrin α6β4 suggests that it could actively contribute to
pancreatic cancer progression.
Integrins regulate many cellular functions such as cell adhesion to
the extracellular matrix and transmission of molecular cues from the
outside microenvironment that can influence cell shape, survival,
proliferation, gene transcription, protein translation, cell migration
and invasion, and tumor development [2]. Their two type I trans-
membrane α and β subunits can associate in different combinations
leading to the formation of at least 25 receptors [9]. The α6β4 in-
tegrin is unique among integrins given that the β4 subunit has a
cytoplasmic domain that is 1000 amino acids longer than other in-
tegrins and it can only associate with the α6 integrin subunit [10].
The α6β4 integrin is primarily expressed on the basal surface of most
epithelia where it functions as an adhesion receptor to maintain
epithelial structure and integrity through the anchoring of the epithe-
lium to its underlying basement membrane through the formation of
hemidesmosomes [11]. The α6β4 integrin is elevated in several types
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of carcinomas, with increased levels of expression correlating with a
highly invasive and motile phenotype [12] as well as reduced patient
survival [13]. However, the α6β4 integrin has been suggested to have
both tumor suppressing and tumor promoting roles. In the presence
of a wild-type p53, the α6β4 can promote apoptosis, but facilitates
survival when p53 is mutant or absent [14]. Similarly, the suppressive
effects of this integrin on tumor progression can be overcome by mu-
tant K-Ras in a skin tumor model [15]. In squamous carcinomas, the
α6β4 integrin has been shown to be released from the hemidesmo-
somes and associate with the actin cytoskeleton after epidermal
growth factor stimulation in a process that is dependent on protein
kinase C α–mediated phosphorylation of serine residues in the integ-
rin β4 subunit [16]. Once released from hemidesmosomes, the α6β4
integrin can cooperate and amplify signaling from multiple growth
factor receptors to promote various aspects of tumor progression in-
cluding cell proliferation, migration, invasion, and metastasis [2,12].
The ability of this integrin to signal synergistically with growth factor
receptors, such as ErbB-2, ErbB-3 [17,18], and c-Met [19], has been
implicated with an invasive phenotype through the activation of sig-
naling intermediates, such as phosphoinositol-3-kinase (PI3-K) [20],
Akt [21], and Rac1 [22]. Rac1 is a member of the Rho family of
GTPases that regulates actin polymerization leading to the formation
of membrane ruffles and lamellae. Rac1 is critical for the migration of
most cell types [23] and acts downstream of the PI3-K pathway [24].
The involvement of the α6β4 integrin in the invasive phenotype
of multiple carcinomas and upregulation of this integrin in pancre-
atic adenocarcinomas prompted us to investigate in vitro how the
α6β4 integrin may contribute to pancreatic cancer cell migration
and invasion. Therefore, the goals of this study were 1) to ascertain
if the integrin α6β4 contributes to the migration and invasion phe-
notype of pancreatic cancer cell lines and 2) to assess mechanisms
governing the contributions of integrin α6β4 to the migratory and
invasive phenotype.
Materials and Methods
Cell Culture and Antibodies
MiaPaCa-2, Panc-1 (from America Type Culture Collection,
ATCC), and Panc-1 subclones were cultured in Dulbecco’s modified
Eagle’s medium (high glucose) with 10% Fetal Plex (Gemini Bio-
Products, West Sacramento, CA), 1% l-glutamine, 1% penicillin,
and 1% streptomycin (GIBCO BRL, Gaithersburg, MD). Suit-2
(obtained from Dr. Takeshi Iwamura, Miyazaki Medical College,
Miyazaki, Japan), ASPC-1, and BXPC-3 (obtained from ATCC) cells
were cultured in RPMI 1640 containing 10% Fetal Plex serum plus
1% l-glutamine, 1% penicillin, and 1% streptomycin. Cells were
harvested using 0.05% trypsin-EDTA and washed three times with
serum-free medium containing 250 μg/ml heat-inactivated BSA
(medium/BSA). The antibodies used include anti-β4 integrin subunit
505 rabbit polyclonal (Arthur Mercurio, University of Massachusetts,
Worchester, MA), 439-9B rat monoclonal (Chemicon, Temecula,
CA), GoH3 rat monoclonal anti-α6 integrin subunit (Santa Cruz Bio-
technologies, Santa Cruz, CA), C-28 rabbit polyclonal anti-c-Met
(Santa Cruz Biotechnologies), purified mouse monoclonal anti-Rac1
antibody (BD Biosciences, San Jose, CA), rabbit polyclonal anti-
Tiam1 antibody (Bethyl Laboratories, Montgomery, TX), MAB1864
rat monoclonal anti-tubulin (Chemicon), and AC-15 mouse mono-
clonal anti-β-actin (Sigma Aldrich, St. Louis, MO).
Immunoblotting
Cells were lysed with RIPA buffer (150 mM NaCl, 0.5 mM
EGTA, 0.1% sodium deoxycholate, 0.1% SDS, 1% Triton X-100,
50 mM Tris-HCl, pH 7.4) containing 15 μg/ml protease inhibitor
cocktail (Sigma Aldrich) and 1 mM PMSF, resolved on a polyacryl-
amide gel, transferred to a nitrocellulose membrane, blocked, and
probed with the indicated primary antibodies. Membranes were
washed, incubated with appropriate horseradish peroxidase–conjugated
secondary antibody and developed using the SuperSignal West Pico
Chemiluminescent Substrate (Pierce Biotechnologies, Rockford, IL)
or Immobilon Western Chemiluminescent HRP Substrate (Millipore,
Billerica, MA).
Fluorescence-Activated Cell Sorting
Suspended cells were incubated with primary antibody or IgG
only for 1 hour at 4°C and washed three times with 1× Dulbecco’s
PBS (pH 7.4) (Gibco, Carlsbad, CA) containing 250 μg/ml heat in-
activated BSA (Dulbecco’s PBS/BSA). Cells were then incubated
with Cy2-conjugated secondary antibody (Jackson Immunoresearch,
West Grove, PA) and analyzed on a FACS-Scan (Becton-Dickinson,
Franklin Lakes, NJ). Relative fluorescence values from the IgG-
only samples were subtracted from the samples treated with pri-
mary antibody.
Migration and Invasion Assays
The upper and bottom surface of Transwell membranes (6.5-mm
diameter, 8-μm pore size; Corning, Corning, NY) were coated with
15 μg/ml of laminin-1 (Trevigen, Gaithersburg, MD) for 30 minutes
at 37°C and then washed three times with medium/BSA for chemo-
taxis studies. For invasion assays, 7.3 μg of Collagen I (Vitrogen/
PureCol, Leimuiden, the Netherlands) was diluted in cold water
and dried onto the upper surface of each Transwell chamber mem-
brane. Matrix was reconstituted with medium without serum for
1 hour before use. Hepatocyte growth factor (HGF, 50 ng/ml, unless
otherwise indicated; Peprotech, Rocky Hill, NJ) diluted in medium/
BSA or medium/BSA alone was added to the bottom chamber. Cells
(50,000) were added to the upper chamber and allowed to migrate
for 4 hours or invade for 6 hours at 37°C. Nonmigrating or non-
invading cells were removed with a cotton swab from the top cham-
ber. Cells remaining in the bottom were fixed with 100% methanol,
stained with 1% crystal violet in 2% ethanol, and quantified visually
from four random fields from each membrane using bright-field op-
tics. Values for triplicate membranes are reported as a mean number
of cells per millimeter squared ± the standard deviation of the mean.
RNA Extraction and Real-Time PCR
Total RNA was extracted from cells using Trizol reagent (Invitro-
gen, Carlsbad, CA). cDNA was synthesized using 5 μg of RNA and
the SuperScript III First-Strand Synthesis System (Invitrogen) as per
the manufacturer’s recommendations. Expression of T-lymphoma
invasion and metastasis (Tiam1) was assessed by real-time PCR using
available probes, reagents, and ABI7000 sequence detector as rec-
ommended by the manufacturer (Applied Biosystems, Foster City,
CA). Real-time PCR was performed at the real-time PCR core facil-
ity, Sealy Center for Cancer Cell Biology, University of Texas Medical
Branch. Duplicate CT values were analyzed in Microsoft Excel using
the comparative CT (ΔΔCT) method as described by the manufac-
turer (Applied Biosystems). The amounts of targets (2−ΔΔCT) were
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obtained by normalizing to endogenous reference (18S) and relative
to a calibrator (one of the experimental samples).
Small Interfering RNA Electroporation
Suspended cells (3 × 106) were electroporated with or without
200 nM of the indicated small interfering RNA (siRNA, 300 V,
500 μF) with the Gene Pulser Xcell System (BioRad Laboratories,
Hercules, CA) and then plated in normal growth medium. Cells were
given fresh medium after 24 hours and harvested after 48 hours. Con-
trol nontargeting siRNA or siRNAs designed to target the integrin β4,
integrin α6, Rac1, and Tiam1 were SMARTPools from Dharmacon
(Chicago, IL). For rescue experiments, cells were electroporated as de-
scribed above, and 48 hours later, cells were transfected with 10 μg of
a human Tiam1 full-length construct (John Exton, Vanderbilt Univer-
sity, Nashville, TN) using 30 μl Lipofectamine 2000 (Invitrogen). The
following day, cells were assayed for migration and invasion.
Clone Selection
The parental Panc-1 cells were sorted for the integrin β4 subunit by
fluorescence-activated cell sorting (FACS) analysis (Becton-Dickinson,
Franklin Lakes, NJ). Cell populations with high and low integrin β4
expression were isolated and further subcloned by dilution cloning.
Individual clones of the sorted population including Panc-1/2G6
low integrin β4 expresser; Panc-1/3D7, and Panc-1/ZCM high integ-
rin β4 expressers were further identified. To isolate the Panc-1/Δcyt
clone, parental Panc-1 cells were transfected with a mutated β4 cDNA
that lacked the cytoplasmic domain with the exception of four amino
acids distal to the transmembrane sequence (β4-Δcyt [25]) (Arthur
Mercurio, University of Massachusetts), using Lipofectamine 2000
(Invitrogen), selected with Genecitin (2 mg/ml) (G418; Invitrogen)
and colonies were screened for expression of β4-Δcyt. Expression of
integrin β4 in cell lines and Panc-1 subclones were confirmed by im-
munoblotting and FACS analyses.
Rac Activity Assays
Cells (1 × 106) were plated on laminin-1 (15 μg/ml, Trevigen)–
coated plates in medium/BSA and allowed to attach and spread for
1 to 2 hours. Plated cells were then left untreated or treated with HGF
(50 ng/ml) for 5 minutes, then harvested with Rac lysis buffer
(50 mM Tris, pH 7.4, 100 mM NaCl, 1% Nonidet P-40, 10% glyc-
erol, 2 mM MgCl2, 15 μg/ml protease inhibitor cocktail, and 1 mM
PMSF) and analyzed for Rac activity as previously described [26]. Ali-
quots of total cell extracts and the eluents from the PBD beads were
analyzed for bound Rac1 molecules by Western blotting analysis.
Statistical Analysis
All experiments were repeated at least three times and data were
reported as mean ± standard deviation. In each case, representative
data are shown. The statistical significance of differences between
groups was calculated using a two-tailed t test (P < .05 was taken
as significant) with the Sigma Stat 2.03 software statistical program
(Systat Software, Point Richmond, CA).
Results
Expression of Integrin α6β4 Correlates with the Ability of
Pancreatic Cancer Cell Lines to Chemotax toward HGF
Integrin α6β4 expression is positively correlated with the invasive
and migratory phenotype of several types of carcinomas including
colon, thyroid, breast, gastric, bladder, and squamous carcinomas
[12]. Due to the high tumor-dissemination rate and early overexpres-
sion of integrin α6β4 associated with pancreatic adenocarcinomas
[8], we hypothesized that pancreatic cancer cell lines with increased
levels of integrin α6β4 expression would migrate at a higher rate than
cells with low levels of integrin α6β4. To test this hypothesis, we
assessed the cell surface expression of both the integrin α6 and β4
subunits by FACS analysis in five pancreatic cancer cell lines and de-
termined how this expression related to their migratory rate toward
HGF. For these experiments, we used HGF as the chemoattractant
because its receptor c-Met is known to cooperate with the integrin
α6β4 to increase motility and invasion of cells in other tumor models
[19,27] and is recognized as an important factor in pancreatic tumor
progression [28]. As shown in Figure 1A, we found that MiaPaCa-2
and Panc-1 cells contained very low levels of cell surface α6β4 integ-
rin, whereas ASPC-1, Suit-2, and BXPC-3 cells each had increasingly
high levels. These results were mirrored to a lesser extent in the im-
munoblot analysis of total protein. Furthermore, all cell lines except
the MiaPaCa2 cells express appreciable amount of c-Met (Figure 1B).
Next, Transwell chemotaxis assays were performed. Here, we found
that the expression level of integrin α6β4, rather than c-Met, cor-
related well with the ability of cells to chemotax toward HGF on
laminin-1, a ligand of integrin α6β4 (Figure 1C ). Moreover, increasing
concentrations of HGF (from 0 to 100 ng/ml) resulted in a steady
Figure 1. Integrin β4 expression in pancreatic cancer cell lines cor-
relates with chemotactic efficiency toward HGF. (A) Select pancre-
atic cell lines, as noted, were assessed for the α6 and β4 integrin
subunit cell surface expression by FACS. Values represent average
mean fluorescence and standard deviation of triplicate determina-
tions. (B) Total cell lysates (80 μg) from pancreatic cancer cell lines
were immunoblotted and probed for expression of integrin β4 sub-
unit, c-Met, and tubulin (loading control). (C) Pancreatic cancer cell
lines were assayed for chemotactic migration using a Transwell
chamber assay toward varying concentrations of HGF as de-
scribed in the Materials and Methods section. Values reported rep-
resent the mean number of cells migrated per millimeter squared ±
standard deviation obtained from triplicate determinations.
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increase in motility of Suit-2 and BXPC-3 cells rather than the plateau
observed with the less aggressive cell lines or bell-shaped curve charac-
teristic of most chemoattractants. Overall, these results indicate that
integrin α6β4 expression positively correlates with the ability of pan-
creatic cancer cells to chemotax toward HGF on a laminin substrate.
Downregulation of α6β4 Integrin Expression Decreases
HGF-stimulated Chemotactic Migration and Invasion of
Pancreatic Cancer Cells
To directly assess the importance of α6β4 integrin in pancreatic
cancer cell motility, we used synthetic siRNAs designed to target
the α6 and β4 subunits to reduce expression of the α6β4 integrin
in ASPC-1 cells. We then assessed the effectiveness of siRNA to
downregulate protein expression by FACS as the plasma membrane–
associated integrins are the species that are expected to function in cell
signaling and adhesion events. After 48 hours of siRNA treatment
against the α6 or β4 subunit, the cell surface expression level of the
α6β4 integrin was decreased and resulted in reduced HGF-stimulated
chemotactic migration and invasion (Figure 2). Similar results were
obtained with Suit-2 cells (data not shown).
To further confirm the positive role of integrin α6β4 in the motile
and invasive phenotype, we isolated clones from the parental Panc-1
cell line, which endogenously expresses low (Panc-1/2G6) or high
levels (Panc-1/ZCM and Panc-1/3D7) of integrin α6β4 but have
similar levels of c-Met (Figure 3A). We then assessed the ability of
these cells to migrate on laminin-1 toward HGF and found that
the levels of expression of the integrin α6β4 correlated with motility
(Figure 3A, right panel). Next, we treated the Panc-1/3D7 cells with
siRNAs targeting the α6 and β4 integrin subunits. We found that
migration and invasion toward HGF were effectively downregulated
by the reduction in α6β4 integrin expression (Figure 3, B and C ) to
a similar extent as seen with the ASPC-1 cells (Figure 2). To test
the effects of signaling transduced from the integrin α6β4 cyto-
plasmic domain on motility, we stably transfected the Panc-1 paren-
tal cell line with cDNA containing a mutant β4, which lacked the
cytoplasmic domain except for the four amino acids distal to the
transmembrane sequence [25] (Panc-1/β4-Δcyt). This construct acts
as a dominant negative [29]. Expression of this construct was de-
termined by FACS (Figure 3, A and D, right panels) because the
antibody used in this study for immunoblot analysis recognizes the
cytoplasmic domain of integrin β4. As shown in Figure 3, A and D,
cells expressing the β4-Δcyt construct had substantially slower migra-
tion rate toward HGF than other Panc-1 clones, whereas it had min-
imal effect on the overall cell surface level of the integrin. In addition,
we show that the Panc-1/3D7 cells have a steady increase in motility
with increasing concentration of HGF as seen with the Suit-2 and
BXPC-3 cells (Figure 1C ). Taken together, these results further con-
firm the involvement of the integrin α6β4 in the motile phenotype
of pancreatic cancer cell lines.
Rac1 Activity Is Required for HGF-Stimulated Migration
and Invasion of Pancreatic Cancer Cells
The integrin α6β4 cooperates with growth factor receptors and af-
fects multiple signaling components that contribute to the increased
migratory and invasive phenotype of cancer cells [2,3,12,18]. Among
the molecules activated by the integrin α6β4 are PI3-K [20] and the
small GTPase Rac1 [22]. Using PI3-K inhibitors wortmannin and
LY294002, we determined that PI3-K activity is critical for the migra-
tion and invasion of the various pancreatic carcinoma cell lines toward
HGF (Figure W1). We further found that HGF substantially induced
the activation of PI3-K activation as revealed by the phosphorylation
status of Akt and the p85 regulatory subunit of PI3-K. However, we
were unable to link the α6β4 integrin to the activation of PI3-K
through either integrin clustering (data not shown) or reduction of
the integrin α6β4 expression by siRNA alone or in conjunction with
HGF treatment (Figure W2). These observations suggest that the ac-
tivation of PI3-K was solely dependent on HGF stimulation. There-
fore, we turned our attention to Rac1. Rac1 can enhance tumor cell
motility and invasion in culture [30] and is overexpressed in 70% of
pancreatic cancer tumor samples [31]. To test the involvement of Rac1
in pancreatic cancer cell motility and invasion, ASPC-1 and Panc1/
3D7 cells were treated with Rac1-specific siRNAs to downregulate
the expression of Rac1 before assessing the cells’ ability to migrate
toward and invade HGF. We found that Rac1 siRNA treatment re-
duced the migration and invasiveness of both cell lines toward HGF
(Figure 4A). Next, we assessed Rac1 activity using a PAK domain
glutathione S-transferase pull-down assay after Panc-1/3D7 cells were
treated with integrin α6 and β4 subunit siRNAs. For these experi-
ments, cells were plated on laminin for 2 hours and then left untreated
or treated with HGF for 5 minutes. Our results indicate that basal
levels of Rac1 activity in the absence of HGF stimulation were high
in these cells and therefore difficult to detect any increase of Rac
activity after HGF stimulation (Figure 4B). However, upon treat-
ment with α6 or β4 siRNAs, Rac1 activity was decreased under basal
and HGF-stimulated conditions (Figure 4, B and C). Similar results
Figure 2. Downregulation of integrin α6β4 decreases chemotactic
migration and invasion of ASPC-1 cells toward HGF. ASPC-1 cells
(3 × 106) were electroporated-only control (Cont) or electroporated
with 200 nM siRNA specific for the integrin subunits β4 or α6, or a
nontargeting control (Non) as indicated and analyzed 48 hours
after siRNA treatment for chemotactic migration (A) (*P < .001
compared to Cont and Non) and invasion (B) (*P < .001 compared
to Non; †P = .02 compared to Cont; ‡P = .004 compared to Cont)
toward medium/BSA only or 50 ng/ml HGF. (C) Effects of siRNA
treatment on integrin α6β4 cell surface expression determined
by FACS as performed in Figure 1A. Values expressed as percent
of electroporated-only controls.
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were obtained with the ASPC-1 cell line (data not shown). Together
these data suggest that Rac1 is required for motility and invasion of
pancreatic cancer cells and that expression of the integrin α6β4 pro-
motes activation of Rac1.
Tiam1 Is Upregulated by the Integrin α6β4 and Is Required
to Activate Rac1 and Promote Migration and Invasion of
Pancreatic Cancer Cells
Having established a link between the expression of integrin α6β4
and Rac1 activation, we next sought to determine molecules that
could connect them to promote increased motility and invasion.
To gain insight into possible candidate molecules, we performed
Affymetrix gene chip analysis on the Panc-1 clones. For this analysis,
RNA from two low α6β4 expressing clones and two high α6β4 ex-
pressing clones were prepared and processed for Affymetrix gene chip
analysis. The results were then processed using the statistical package
S-Plus Array Analyzer (S-PLUS). Differential expression testing was
determined using the local pooled-error test to determine genes dif-
ferentially expressed as a consequence of α6β4 expression to a 99%
confidence level. Among these results, we found that the high α6β4
integrin–expressing clones expressed significantly more Tiam1, a
Rac-specific guanine nucleotide exchange factor (GEF) that has been
implicated in cancer cell migration, invasion, and tumor progression
[32,33]. To validate these results, we investigated the expression of
Tiam1 in various pancreatic cancer cell lines. Using real-time PCR
and immunoblot analysis, we found that Tiam1 was increased in
three of the four pancreatic cancer cell lines (Panc-1/3D7, Suit-2,
and BXPC-3) that overexpressed the α6β4 integrin. In addition,
we discovered that the Panc-1/Δcyt cells, which are unable to signal
through the β4 subunit, did not express Tiam1 (Figure 5, A and B).
Next, we investigated if Tiam1 expression facilitated HGF-stimulated
chemotactic migration and invasion and if Tiam1 was responsible
for promoting Rac1 activity in cells with increased expression levels
of integrin α6β4. After 48 hours of treatment with Tiam1-specific
siRNAs, we found that Tiam1 siRNA reduced the migration and in-
vasion of Panc-1/3D7 cells toward HGF (Figure 5C ). Moreover, the
Figure 3. Integrin α6β4 expression is required for the migration and invasion of pancreatic cancer cell lines in vitro. (A) Total cell lysates
(80 μg) from indicated Panc-1 cell lines were immunoblotted and probed for integrin β4 subunit, c-Met, and actin (loading control) ex-
pression (left panel). Pancreatic cancer cell lines were assayed for migration toward medium/BSA only or 50 ng/ml HGF (right panel).
(*P < .001 compared to Panc-1). (B) Panc-1/3D7 cells (3 × 106) were treated with siRNA as described in Figure 2 and assayed for
chemotactic migration (*P < .001 compared to Cont and Non) and invasion toward medium/BSA or 50 ng/ml HGF (*P = .002 compared
to Cont and P = .006 compared to Non; ‡P < .001 compared to Cont and P = .002 compared to non). (C) Integrin α6β4 cell surface
expression determined by FACS to confirmed downregulation levels from (B). (D) Panc-1, Panc-1/3D7 (high integrin β4 expression), and
Panc-1 β4-Δcyt cells were assayed for migration toward increasing concentrations of HGF (left panel). The level of integrin α6β4 expres-
sion from these cells was confirmed by FACS (right panel).
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migratory phenotype that was suppressed with Tiam1 siRNA treat-
ment was rescued by the transfection of a full-length construct of
Tiam1 (Figure 5D). Next, we investigated whether increased Tiam1
levels contributed to the high levels of Rac1 activity using siRNA.
We found that Tiam1-specific siRNAs lead to a substantial decrease
in Rac1 activity (Figure 5E ), similar to that observed with α6 or β4
integrin–specific siRNAs (Figure 4). Additionally, cells treated with
integrin β4 and α6 siRNAs, alone or in combination, displayed a
decrease in Tiam1 expression (Figure 5F ). Notably, the combination
of α6β4 siRNAs was most efficacious in reducing Tiam1 expression.
Therefore, we hypothesized that if the upregulation of Tiam1 was
instrumental to the enhanced migration and invasion seen with high
α6β4 integrin expression then the exogenous expression of Tiam1
would be able to mimic elevated levels of α6β4 integrin. For these
experiments, we transiently transfected the low integrin β4 expressing
Panc-1/2G6 clone with a full-length Tiam1 construct and assessed
their migratory and invasive ability toward HGF. We noted that
the exogenous Tiam1 expression increased the migration and in-
vasion of the Panc-1/2G6 subclone compared to vector-transfected
cells (Figure 6). Together, these data indicate that Tiam1 expression
correlates well with α6β4 integrin expression and that this exchange
factor promotes the activation of Rac1 as well as HGF-induced che-
motactic migration and invasion of the majority of pancreatic cancer
cells tested.
Discussion
The integrin α6β4 is associated with carcinoma progression and
subsequent metastasis through its ability to enhance motility and in-
vasiveness of cancer cells [3]. However, the role of this integrin in
pancreatic cancers has remained underexplored. We and others have
shown that the integrin α6β4 is overexpressed in pancreatic cancers
when compared to normal pancreas and chronic pancreatitis [4–8],
which occurs early in pancreatic adenocarcinoma tumor progression
[8]. In the current study, we extended our observations of the role
of α6β4 integrin in pancreatic cancers to show that there is a good
correlation of integrin α6β4 expression and the migratory potential
of pancreatic carcinoma cells. Using siRNA technology to limit ex-
pression of the integrin α6 and β4 subunits, we establish that this
promigratory and proinvasive integrin facilitates HGF-stimulated
motility and invasion of pancreatic cancer cells in vitro. Moreover,
our data support other studies demonstrating that signaling through
the α6β4 integrin and c-Met cooperate to promote motility and
invasion of cancer cells [19,27]. One study suggests that the full on-
cogenic potential of c-Met requires the α6β4 integrin during tumori-
genesis [34]. We further demonstrate that α6β4 integrin expression
is required to promote Rac1 activation through the upregulation of
specific Rac GEFs.
Rac1 is a Rho family GTPase that enhances tumor cell migration
and invasion in culture [30] and is activated downstream of integrin
α6β4 to induce invasion of breast cancer cells that expressed integrin
α6β4 [20,22]. Similarly, we report that Rac1 is required for pancreatic
cancer cells to migrate and invade toward HGF and that expression of
the integrin α6β4 promotes activation of Rac1. The activity of Rac is
tightly regulated by GEFs and GTPase-activating proteins that transi-
tion GTPases between an inactive state (GDP-bound) and active state
(GTP-bound). Several Rac GEFs have been shown to act downstream
of β1 integrin signaling [35]; however, little is known about their as-
sociation with the α6β4 integrin. In this study, we highlight a novel
Figure 4. Rac1 is required for the chemotactic migration and inva-
sive potential toward HGF. ASPC-1 and Panc-1/3D7 cells (3 × 106)
were electroporated only (Cont) or electroporated with 200 nM
siRNA specific for Rac1 or a nontargeting control (Non) as indi-
cated and analyzed 48 hours after siRNA treatment for chemo-
tactic migration and invasion (A) toward medium/BSA or 50 ng/
ml HGF; *P < .001 compared to Cont and Non. Immunoblot of
cell lysates was used to confirm downregulation of Rac1 for the
ASPC-1 cells (lower left) and Panc-1/3D7 cells (lower right). (B)
Panc-1/3D7 cells (3 × 106) were electroporated only (Cont), treated
with 200 nM siRNA specific for the integrin subunits β4 and α6
or a nontargeting control (Non) as indicated. After 48 hours of
siRNA treatment, cells (3 × 106) were plated on laminin-1 and left
untreated or treated for 5 minutes with 50 ng/ml HGF. Cell lysates
were then analyzed for Rac1 activity using the PBD binding assay
as described in the Materials and Methods section. (C) Densito-
metric analysis of three different exposures of immunoblots from
(B) of activated (PAK-associated) Rac1. Data are reported as values
for activated Rac1 divided by value for total cellular Rac1. *P <
.001 compared to Cont and Non, BSA, and HGF. Inset shows
immunoblot of integrin β4 to confirm target downregulation and
actin as loading control. Data are representative of three indepen-
dent experiments.
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mechanism by which integrin α6β4 affects activation of Rac1 through
the upregulation of the Rac1-specific GEF, Tiam1.
Tiam1 was originally identified as an invasion and metastasis-
inducing gene by proviral tagging in combination with in vitro selec-
tion for invasiveness in T-lymphoma cells [33] and subsequently
found to selectively activate the Rho family GTPase Rac [36]. The
role of Tiam1 in cell migration, invasion, and metastasis is not lim-
ited to T lymphoma, as this exchange factor is involved in promoting
tumor progression in other cancers such as colorectal, breast, and
lung, as well as Ras-induced skin tumors [32]. In this study, we
found that expression of Tiam1 was required for pancreatic cancer
cells to activate Rac1 and correlated with HGF-induced migration
Figure 5. Tiam1 expression is required for Rac1 activity, migration, and invasion toward HGF of most pancreatic cancer cell lines that
have high levels of integrin α6β4. (A) Pancreatic cancer cell lines were assessed for Tiam1 mRNA expression with real-time PCR. Data
were normalized to 18S and reported relative to MiaPaCa2. (B) Lysates from the indicated cell lines were immunoblotted for Tiam1 (top
panels) and tubulin as a loading control (bottom panels). (C) Panc-1/3D7 cells (3 × 106) were electroporated only (Cont), or electropo-
rated with 200 nM siRNA that is nontargeting (Non) or specific for Tiam1, as indicated, and analyzed 48 hours after siRNA treatment for
chemotactic migration on laminin-1 or collagen invasion toward 50 ng/ml of HGF; *P < .001 compared to Cont and Non-treated cells.
Immunoblot of Tiam1 for siRNA target confirmation and actin as loading control (top panel). (D) Panc-1/3D7 cells were either treated
with 200 nM siRNA specific for Tiam1 or with a nontargeting control (Non) as indicated. After 48 hours of siRNA treatment, cells were
left untreated (−) or transfected with vector or a full-length Tiam1 construct. After 48 hours, cells were assessed for their ability to
migrate toward HGF (bottom panel) as in (C). Immunoblot analysis demonstrates Tiam1 levels after Tiam1 transfection and siRNA ab-
lation with actin as loading control (top panel). *P < .001 compared to Non/vector and Non/Tiam1 FL; ‡P = .001 compared to Tiam1/
vector. (E) Panc-1/3D7 cells from (C) were assessed for Rac1 activity as performed in Figure 4C. Graph in (E) shows densitometry anal-
ysis from two different blot exposures; *P < .001 compared to Cont/BSA; †P = .003 compared to Non/BSA; ‡P < .001 compared to
Cont and Non/HGF. Data are representative of three independent experiments. (F) Panc-1/3D7 cells (3 × 106) were electroporated only
(Cont), treated with 200 nM siRNA specific for the integrin subunits β4 or α6, alone or in combination, as indicated. After 48 hours of
siRNA treatment, cells (3 × 106) were lysed and probed for the presence of Tiam1, integrin β4, and actin.
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and invasion in an integrin α6β4–dependent manner. We also dem-
onstrated that the cytoplasmic tail of the integrin α6β4, known to be
responsible for the signaling transduced from this integrin [19,20],
is required for expression of Tiam1 because the Panc-1/Δcyt clone
lacked expression of Tiam1. In cells that are less motile and inva-
sive and contain low expression levels of both integrin α6β4 and
Tiam1, exogenous expression of Tiam1 aided HGF-induced migra-
tion and invasion (Figure 6). Interestingly, we found that exogenous
expression of Tiam1 did not increase the high migratory levels of
cells with endogenous expression of integrin α6β4 and Tiam1
(Figure 5D). One reason for this observation may be due to a role
of Tiam1 as a rate-limiting step during HGF-mediated migration but
not basal migration. Alternatively, integrin α6β4 could also regulate
other properties of Tiam1, such as its activity and/or localization,
two mechanisms that are critical for the function of this protein to
activate Rac. Certainly, the activation of Tiam1 downstream of the
α6β4 integrin does not appear to require the PI3K pathway be-
cause PI3K is not activated in the absence of HGF stimulation
and HGF does not promote the activation of Rac. These observa-
tions are in accordance with the fact that Tiam1 activation, unlike
that of many other Rac GEFs, does not necessarily require PI3K
[37]. Although the activation of Tiam1 downstream of HGF has re-
cently been established in vascular endothelial permeability studies
[38,39], our work highlights a previously unrecognized connection
between Tiam1, the motility promoting functions of HGF/c-Met,
and pancreatic cancer.
It is interesting to note that ASPC-1 cells express high levels of
integrin α6β4 and have high Rac1 activity, but lack expression of
Tiam1. These data imply that an additional exchange factor could
be responsible for Rac1 activation by the integrin α6β4 to promote
the migratory and invasive phenotype observed. One candidate is
Vav1, as it was shown to play a role in pancreatic cancer tumorigen-
esis [40], but others such as Tiam2, Trio, Sos, and Pix could also be
involved, as these GEFs are known to activate Rac [41,42]. One pos-
sibility for the discrepancy in Tiam1 expression could be the origin
from which these pancreatic cancer cell lines were derived because
the ASPC-1 cells were isolated from a metastasis to the ascites [43]
and the Panc-1 cells were isolated from a primary tumor of the head
of the pancreas [44]. In support of the idea that GEF expression
could be cell type specific, in breast cancer cell lines GEFs other than
Tiam1 are elevated by the α6β4 integrin to promote Rac activity
(M. Chen and K. L. O’Connor, unpublished observation). The con-
cept that the α6β4 integrin can affect similar changes, such as the
activation of Rac, through the cell type–specific upregulation of spe-
cific factors is intriguing and may help to explain why the α6β4 in-
tegrin can promote the migratory and invasive phenotype of many
types of cells. However, there remains much to be learned about
the mechanisms of how integrin α6β4 affects migration and invasion
of cancer cells, especially how the α6β4 integrin can affect GEF ex-
pression and its subsequent activation.
The genesis of activating mutations in K-Ras is one of the first
events in pancreatic adenocarcinoma progression that occurs at a fre-
quency of around 85% [45]. Interestingly, signaling induced from
this type of oncogenic Ras has been reported to have differential ef-
fects on Tiam1 expression, which can, in turn, affect tumor develop-
ment and progression. For example, the overexpression of Tiam1
in normal polarized epithelial cells has been shown to tighten cell–
cell junctions thereby inhibiting HGF-mediated scattering [46]. This
inhibition can be reversed by oncogenic Ras signaling, which pro-
motes a decrease in Tiam1 expression [47]. However, effective ini-
tiation of chemically induced epidermal tumors by oncogenic Ras
in vivo requires Tiam1 expression and Rac signaling [48]. Therefore,
if oncogenic Ras signaling has the potential to downregulate Tiam1
expression, then other GEFs must be used to induce migration and
invasion of tumor cells. Alternatively, other signaling pathways could
be activated to increase Tiam1 and compensate for the Ras-induced
Tiam1 loss. In the chemical induction model for epidermal tumors,
for example, the integrin α6β4 is required for Ras to promote the
formation of human squamous cell carcinomas [49]. Because our re-
sults show that integrin α6β4 can upregulate Tiam1 expression and
this integrin is overexpressed at an early stage during pancreatic
adenocarcinoma progression [8], we suggest that increased expres-
sion of integrin α6β4 could restore Tiam1 expression after its down-
regulation by oncogenic Ras signaling in tumors. Taken together,
these observations suggest a possible mechanism involving the up-
regulation of Tiam1 and the subsequent activation of Rac for the
cooperation between integrin α6β4 and Ras signaling in pancreatic
adenocarcinomas that could contribute to its aggressive nature.
In summary, this study reports that integrin α6β4 cell surface ex-
pression in pancreatic cancer cells correlates with increased HGF-
induced chemotactic motility. In addition, we show that integrin
α6β4 expression is required to activate Rac1 and promote HGF-
induced motility and invasion. This activation of Rac is mediated
by the upregulation of the Rac-specific GEF, Tiam1. Our findings
are consistent with the scenario that the α6β4 integrin cooperates
with c-Met and further demonstrates that one level of cooperation
lies within the Tiam1-Rac1 pathway. Our study in pancreatic cancer
extends findings in other cancer systems that highlight the important
contribution of the integrin α6β4 expression and downstream signal-
ing events to induce tumor cell migration and invasion.
Figure 6. Exogenous Tiam1 promotes migration and invasion of
pancreatic cancer cells. (A) Panc-1 2G6 cells (low integrin β4 ex-
pression) were transiently transfected with a full-length construct
of Tiam1 and then assessed for chemotactic migration on laminin-1
and collagen invasion toward 50 ng/ml of HGF. *P< .001 compared
to pcDNA transfected cells. (B) Immunoblot of Tiam1 to confirm
expression of full-length Tiam1 and actin as loading control. Trans-
fection efficiency was approximately 60%.
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Figure W1. PI3-K is required for chemotactic migration and invasion toward HGF. ASPC-1 (A, C) and Panc-1/3D7 clone (B, D) cells were
incubated with DMSO (1%), LY294002 (25 μM), or wortmannin (100 nM) for 30 minutes at room temperature with and without ZVad (a
broad-spectrum caspase inhibitor) as noted. Cells (3 × 106) were then allowed to migrate (A, B) for 4 hours or invade (C, D) for 6 hours
toward 50 ng/ml HGF in the presence of drug as described in the Materials and Methods section.
Figure W2. Integrin α6β4 expression does not influence activation of PI3-K. Panc-1/3D7 cells (3 × 106) were electroporated only (Cont) or
electroporated with 200 nM siRNA specific for α6 and β4 or a nontargeting (Non) control as indicated. After 48 hours of siRNA treat-
ment, cells were plated on laminin-1 and left untreated or treated for 5 minutes with 50 ng/ml HGF. Cell lysates were then analyzed for
p85α activation by immunoprecipitating with an anti-phosphotyrosine antibody (clone 4G10) and then immunoblotting with a p85α
antibody (A). (B) Immunoblot of integrin β4 to confirm target downregulation using actin as loading control. (C) Panc-1/3D7 cells were
treated with indicated siRNAs as in (A); cell lysates were then analyzed for the presence of phosphorylated AKT (pAKT) and actin as
loading control.
